Description

Lib2-1, a macrocyclic peptide, is an IL-17C/IL-17RE interaction inhibitor. Lib2-1 can be used for autoimmune and inflammatory diseases research[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-immunoregulation–C81H108N18O23S—-[1]Silong Zhai, et al. PepScaf: Harnessing Machine Learning with In Vitro Selection toward De Novo Macrocyclic Peptides against IL-17C/IL-17RE Interaction. J Med Chem. 2023 Aug 24;66(16):11187-11200. –2983116-47-6–1733.90–99.63–O=C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC2=CNC=N2)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H](CC4=CC=C(C=C4)O)C(N[C@@H](C)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CC5=CC=C(C=C5)O)C(NCC(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(NC6)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CSC[C@@H](C(NCC(N)=O)=O)NC6=O–Inflammation/Immunology–DMSO : 100 mg/mL (ultrasonic)–Interleukin Related—-Immunology/Inflammation–Peptides